Sarepta Therapeutics, Inc. (SRPT)

20.63 -0.05 (-0.24%) USD  |  NASDAQ  |  Apr 22, 15:05
More

Sarepta Therapeutics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for SRPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Keros Therapeutics, Inc. Upgrade
Merck & Co., Inc. Upgrade
PTC Therapeutics, Inc. Upgrade
REGENXBIO, Inc. Upgrade
Gilead Sciences, Inc. Upgrade